Basic Science 2023
DOI: 10.1136/heartjnl-2023-bcs.269
|View full text |Cite
|
Sign up to set email alerts
|

BS56 An epigenomic investigation of atrial fibrillation in a paired left and right atrial cohort

Abstract: vasodilator, but would not compromise blood pressure or myocardial contractility. Aims We investigated i) The vasodilatory properties of Chroman 1 (Ch1) (a selective ROCK 2 inhibitor), relative to Fasudil, to ascertain whether this agent could demonstrate effective vasorelaxation and ii) Performed a dose response experiment using a rat model in-vivo, to test the effects of Ch1 on myocardial contractility and left ventricular ejection fraction (LVEF %), mean arterial pressure (MAP) and heart rate. Methods Thora… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles